Larvol Delta - In-vitro-and-clinical-studies-of-gene-therapy-with-recombinant-human-adenovirusp53-injection-for-malignant-melanoma

Gendicine (rAd-p53 Gene Therapy) - Benda Pharma

http://www.ncbi.nlm.nih.gov/pubmed/30618300

Jan 9, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next